HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsDaniel I. Swerdlow, Rudi G. J. Westendorp, Maarten Leusink et al.|The Lancet|2014Cited by 709
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation studyAmand F. Schmidt, Andrzej Pająk, Daniel I. Swerdlow et al.|The Lancet Diabetes & Endocrinology|2016Cited by 390
Education and wealth inequalities in healthy ageing in eight harmonised cohorts in the ATHLOS consortium: a population-based studyYu‐Tzu Wu, Matthew Prina, Christina Daskalopoulou et al.|The Lancet Public Health|2020Cited by 160
Dietary polyphenol intake and risk of type 2 diabetes in the Polish arm of the Health, Alcohol and Psychosocial factors in Eastern Europe (HAPIEE) studyGiuseppe Grosso, Andrzej Pająk|British Journal Of Nutrition|2017Cited by 88
The Southern European Atlantic diet and all-cause and cause-specific mortality: a European multicohort studyAdrián Carballo‐Casla, Martin Bobák, Dénes Stefler et al.|European Journal of Preventive Cardiology|2023Cited by 21